0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oxaprozin Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-12G7887
Home | Market Reports | Health| Pharmacy
Global Oxaprozin Market Insights and Forecast to 2028
BUY CHAPTERS

Global Oxaprozin Market Research Report 2025

Code: QYRE-Auto-12G7887
Report
July 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Oxaprozin Market

The global market for Oxaprozin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Oxaprozin (Actirin) is a drug used for the treatment of rheumatoid arthritis, rheumatoid arthritis, osteoarthritis, ankylosis, cervical, shoulder and wrist syndrome, periarthritis of the shoulder, gout, and after trauma and surgery anti-inflammatory analgesia.
North American market for Oxaprozin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Oxaprozin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Oxaprozin include Pfizer, Helsinn, Taisho, Ildong, PD-Rx Pharmaceuticals, Therapicon, Neolpharma, Apotex Corporation, Yichang Dongyangguang Changjiang Pharmaceutical, Hubei Baike Hengdi Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oxaprozin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oxaprozin.
The Oxaprozin market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oxaprozin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oxaprozin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Oxaprozin Market Report

Report Metric Details
Report Name Oxaprozin Market
Segment by Type
  • Tablets
  • Capsule
Segment by Application
  • Rheumatoid Arthritis
  • Chronic Infectious Arthritis
  • Osteoarthritis
  • Ankylosing Spondylitis
  • Neck Shoulder Wrist Syndrome
  • Periarthritis Of Shoulder
  • Gout
  • Anti-Inflammatory and Analgesic Effects After Trauma and Surgery
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Helsinn, Taisho, Ildong, PD-Rx Pharmaceuticals, Therapicon, Neolpharma, Apotex Corporation, Yichang Dongyangguang Changjiang Pharmaceutical, Hubei Baike Hengdi Pharmaceutical, Fuan Pharmaceutical Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Oxaprozin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Oxaprozin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Oxaprozin Market report?

Ans: The main players in the Oxaprozin Market are Pfizer, Helsinn, Taisho, Ildong, PD-Rx Pharmaceuticals, Therapicon, Neolpharma, Apotex Corporation, Yichang Dongyangguang Changjiang Pharmaceutical, Hubei Baike Hengdi Pharmaceutical, Fuan Pharmaceutical Group

What are the Application segmentation covered in the Oxaprozin Market report?

Ans: The Applications covered in the Oxaprozin Market report are Rheumatoid Arthritis, Chronic Infectious Arthritis, Osteoarthritis, Ankylosing Spondylitis, Neck Shoulder Wrist Syndrome, Periarthritis Of Shoulder, Gout, Anti-Inflammatory and Analgesic Effects After Trauma and Surgery, Other

What are the Type segmentation covered in the Oxaprozin Market report?

Ans: The Types covered in the Oxaprozin Market report are Tablets, Capsule

1 Oxaprozin Market Overview
1.1 Product Definition
1.2 Oxaprozin by Type
1.2.1 Global Oxaprozin Market Value Comparison by Type (2024 VS 2031)
1.2.2 Tablets
1.2.3 Capsule
1.3 Oxaprozin by Application
1.3.1 Global Oxaprozin Market Value by Application (2024 VS 2031)
1.3.2 Rheumatoid Arthritis
1.3.3 Chronic Infectious Arthritis
1.3.4 Osteoarthritis
1.3.5 Ankylosing Spondylitis
1.3.6 Neck Shoulder Wrist Syndrome
1.3.7 Periarthritis Of Shoulder
1.3.8 Gout
1.3.9 Anti-Inflammatory and Analgesic Effects After Trauma and Surgery
1.3.10 Other
1.4 Global Oxaprozin Market Size Estimates and Forecasts
1.4.1 Global Oxaprozin Revenue 2020-2031
1.4.2 Global Oxaprozin Sales 2020-2031
1.4.3 Global Oxaprozin Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Oxaprozin Market Competition by Manufacturers
2.1 Global Oxaprozin Sales Market Share by Manufacturers (2020-2025)
2.2 Global Oxaprozin Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Oxaprozin Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Oxaprozin, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oxaprozin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oxaprozin, Product Type & Application
2.7 Global Key Manufacturers of Oxaprozin, Date of Enter into This Industry
2.8 Global Oxaprozin Market Competitive Situation and Trends
2.8.1 Global Oxaprozin Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Oxaprozin Players Market Share by Revenue
2.8.3 Global Oxaprozin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Oxaprozin Market Scenario by Region
3.1 Global Oxaprozin Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Oxaprozin Sales by Region: 2020-2031
3.2.1 Global Oxaprozin Sales by Region: 2020-2025
3.2.2 Global Oxaprozin Sales by Region: 2026-2031
3.3 Global Oxaprozin Revenue by Region: 2020-2031
3.3.1 Global Oxaprozin Revenue by Region: 2020-2025
3.3.2 Global Oxaprozin Revenue by Region: 2026-2031
3.4 North America Oxaprozin Market Facts & Figures by Country
3.4.1 North America Oxaprozin Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Oxaprozin Sales by Country (2020-2031)
3.4.3 North America Oxaprozin Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Oxaprozin Market Facts & Figures by Country
3.5.1 Europe Oxaprozin Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Oxaprozin Sales by Country (2020-2031)
3.5.3 Europe Oxaprozin Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oxaprozin Market Facts & Figures by Region
3.6.1 Asia Pacific Oxaprozin Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Oxaprozin Sales by Region (2020-2031)
3.6.3 Asia Pacific Oxaprozin Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Oxaprozin Market Facts & Figures by Country
3.7.1 Latin America Oxaprozin Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Oxaprozin Sales by Country (2020-2031)
3.7.3 Latin America Oxaprozin Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oxaprozin Market Facts & Figures by Country
3.8.1 Middle East and Africa Oxaprozin Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Oxaprozin Sales by Country (2020-2031)
3.8.3 Middle East and Africa Oxaprozin Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oxaprozin Sales by Type (2020-2031)
4.1.1 Global Oxaprozin Sales by Type (2020-2025)
4.1.2 Global Oxaprozin Sales by Type (2026-2031)
4.1.3 Global Oxaprozin Sales Market Share by Type (2020-2031)
4.2 Global Oxaprozin Revenue by Type (2020-2031)
4.2.1 Global Oxaprozin Revenue by Type (2020-2025)
4.2.2 Global Oxaprozin Revenue by Type (2026-2031)
4.2.3 Global Oxaprozin Revenue Market Share by Type (2020-2031)
4.3 Global Oxaprozin Price by Type (2020-2031)
5 Segment by Application
5.1 Global Oxaprozin Sales by Application (2020-2031)
5.1.1 Global Oxaprozin Sales by Application (2020-2025)
5.1.2 Global Oxaprozin Sales by Application (2026-2031)
5.1.3 Global Oxaprozin Sales Market Share by Application (2020-2031)
5.2 Global Oxaprozin Revenue by Application (2020-2031)
5.2.1 Global Oxaprozin Revenue by Application (2020-2025)
5.2.2 Global Oxaprozin Revenue by Application (2026-2031)
5.2.3 Global Oxaprozin Revenue Market Share by Application (2020-2031)
5.3 Global Oxaprozin Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Oxaprozin Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Oxaprozin Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Helsinn
6.2.1 Helsinn Company Information
6.2.2 Helsinn Description and Business Overview
6.2.3 Helsinn Oxaprozin Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Helsinn Oxaprozin Product Portfolio
6.2.5 Helsinn Recent Developments/Updates
6.3 Taisho
6.3.1 Taisho Company Information
6.3.2 Taisho Description and Business Overview
6.3.3 Taisho Oxaprozin Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Taisho Oxaprozin Product Portfolio
6.3.5 Taisho Recent Developments/Updates
6.4 Ildong
6.4.1 Ildong Company Information
6.4.2 Ildong Description and Business Overview
6.4.3 Ildong Oxaprozin Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Ildong Oxaprozin Product Portfolio
6.4.5 Ildong Recent Developments/Updates
6.5 PD-Rx Pharmaceuticals
6.5.1 PD-Rx Pharmaceuticals Company Information
6.5.2 PD-Rx Pharmaceuticals Description and Business Overview
6.5.3 PD-Rx Pharmaceuticals Oxaprozin Sales, Revenue and Gross Margin (2020-2025)
6.5.4 PD-Rx Pharmaceuticals Oxaprozin Product Portfolio
6.5.5 PD-Rx Pharmaceuticals Recent Developments/Updates
6.6 Therapicon
6.6.1 Therapicon Company Information
6.6.2 Therapicon Description and Business Overview
6.6.3 Therapicon Oxaprozin Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Therapicon Oxaprozin Product Portfolio
6.6.5 Therapicon Recent Developments/Updates
6.7 Neolpharma
6.7.1 Neolpharma Company Information
6.7.2 Neolpharma Description and Business Overview
6.7.3 Neolpharma Oxaprozin Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Neolpharma Oxaprozin Product Portfolio
6.7.5 Neolpharma Recent Developments/Updates
6.8 Apotex Corporation
6.8.1 Apotex Corporation Company Information
6.8.2 Apotex Corporation Description and Business Overview
6.8.3 Apotex Corporation Oxaprozin Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Apotex Corporation Oxaprozin Product Portfolio
6.8.5 Apotex Corporation Recent Developments/Updates
6.9 Yichang Dongyangguang Changjiang Pharmaceutical
6.9.1 Yichang Dongyangguang Changjiang Pharmaceutical Company Information
6.9.2 Yichang Dongyangguang Changjiang Pharmaceutical Description and Business Overview
6.9.3 Yichang Dongyangguang Changjiang Pharmaceutical Oxaprozin Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Yichang Dongyangguang Changjiang Pharmaceutical Oxaprozin Product Portfolio
6.9.5 Yichang Dongyangguang Changjiang Pharmaceutical Recent Developments/Updates
6.10 Hubei Baike Hengdi Pharmaceutical
6.10.1 Hubei Baike Hengdi Pharmaceutical Company Information
6.10.2 Hubei Baike Hengdi Pharmaceutical Description and Business Overview
6.10.3 Hubei Baike Hengdi Pharmaceutical Oxaprozin Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Hubei Baike Hengdi Pharmaceutical Oxaprozin Product Portfolio
6.10.5 Hubei Baike Hengdi Pharmaceutical Recent Developments/Updates
6.11 Fuan Pharmaceutical Group
6.11.1 Fuan Pharmaceutical Group Company Information
6.11.2 Fuan Pharmaceutical Group Description and Business Overview
6.11.3 Fuan Pharmaceutical Group Oxaprozin Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Fuan Pharmaceutical Group Oxaprozin Product Portfolio
6.11.5 Fuan Pharmaceutical Group Recent Developments/Updates
6.12 Hubei Baike Hengdi Pharmaceutical
6.12.1 Hubei Baike Hengdi Pharmaceutical Company Information
6.12.2 Hubei Baike Hengdi Pharmaceutical Description and Business Overview
6.12.3 Hubei Baike Hengdi Pharmaceutical Oxaprozin Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Hubei Baike Hengdi Pharmaceutical Oxaprozin Product Portfolio
6.12.5 Hubei Baike Hengdi Pharmaceutical Recent Developments/Updates
6.13 Pfizer
6.13.1 Pfizer Company Information
6.13.2 Pfizer Description and Business Overview
6.13.3 Pfizer Oxaprozin Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Pfizer Oxaprozin Product Portfolio
6.13.5 Pfizer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oxaprozin Industry Chain Analysis
7.2 Oxaprozin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oxaprozin Production Mode & Process Analysis
7.4 Oxaprozin Sales and Marketing
7.4.1 Oxaprozin Sales Channels
7.4.2 Oxaprozin Distributors
7.5 Oxaprozin Customer Analysis
8 Oxaprozin Market Dynamics
8.1 Oxaprozin Industry Trends
8.2 Oxaprozin Market Drivers
8.3 Oxaprozin Market Challenges
8.4 Oxaprozin Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Oxaprozin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Oxaprozin Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Oxaprozin Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Oxaprozin Sales (KG) of Key Manufacturers (2020-2025)
 Table 5. Global Oxaprozin Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Oxaprozin Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Oxaprozin Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Oxaprozin Average Price (US$/G) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Oxaprozin, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Oxaprozin, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Oxaprozin, Product Type & Application
 Table 12. Global Key Manufacturers of Oxaprozin, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Oxaprozin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oxaprozin as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Oxaprozin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Oxaprozin Sales by Region (2020-2025) & (KG)
 Table 18. Global Oxaprozin Sales Market Share by Region (2020-2025)
 Table 19. Global Oxaprozin Sales by Region (2026-2031) & (KG)
 Table 20. Global Oxaprozin Sales Market Share by Region (2026-2031)
 Table 21. Global Oxaprozin Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Oxaprozin Revenue Market Share by Region (2020-2025)
 Table 23. Global Oxaprozin Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Oxaprozin Revenue Market Share by Region (2026-2031)
 Table 25. North America Oxaprozin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Oxaprozin Sales by Country (2020-2025) & (KG)
 Table 27. North America Oxaprozin Sales by Country (2026-2031) & (KG)
 Table 28. North America Oxaprozin Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Oxaprozin Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Oxaprozin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Oxaprozin Sales by Country (2020-2025) & (KG)
 Table 32. Europe Oxaprozin Sales by Country (2026-2031) & (KG)
 Table 33. Europe Oxaprozin Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Oxaprozin Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Oxaprozin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Oxaprozin Sales by Region (2020-2025) & (KG)
 Table 37. Asia Pacific Oxaprozin Sales by Region (2026-2031) & (KG)
 Table 38. Asia Pacific Oxaprozin Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Oxaprozin Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Oxaprozin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Oxaprozin Sales by Country (2020-2025) & (KG)
 Table 42. Latin America Oxaprozin Sales by Country (2026-2031) & (KG)
 Table 43. Latin America Oxaprozin Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Oxaprozin Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Oxaprozin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Oxaprozin Sales by Country (2020-2025) & (KG)
 Table 47. Middle East and Africa Oxaprozin Sales by Country (2026-2031) & (KG)
 Table 48. Middle East and Africa Oxaprozin Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Oxaprozin Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Oxaprozin Sales (KG) by Type (2020-2025)
 Table 51. Global Oxaprozin Sales (KG) by Type (2026-2031)
 Table 52. Global Oxaprozin Sales Market Share by Type (2020-2025)
 Table 53. Global Oxaprozin Sales Market Share by Type (2026-2031)
 Table 54. Global Oxaprozin Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Oxaprozin Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Oxaprozin Revenue Market Share by Type (2020-2025)
 Table 57. Global Oxaprozin Revenue Market Share by Type (2026-2031)
 Table 58. Global Oxaprozin Price (US$/G) by Type (2020-2025)
 Table 59. Global Oxaprozin Price (US$/G) by Type (2026-2031)
 Table 60. Global Oxaprozin Sales (KG) by Application (2020-2025)
 Table 61. Global Oxaprozin Sales (KG) by Application (2026-2031)
 Table 62. Global Oxaprozin Sales Market Share by Application (2020-2025)
 Table 63. Global Oxaprozin Sales Market Share by Application (2026-2031)
 Table 64. Global Oxaprozin Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Oxaprozin Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Oxaprozin Revenue Market Share by Application (2020-2025)
 Table 67. Global Oxaprozin Revenue Market Share by Application (2026-2031)
 Table 68. Global Oxaprozin Price (US$/G) by Application (2020-2025)
 Table 69. Global Oxaprozin Price (US$/G) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 73. Pfizer Oxaprozin Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Helsinn Company Information
 Table 76. Helsinn Description and Business Overview
 Table 77. Helsinn Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 78. Helsinn Oxaprozin Product
 Table 79. Helsinn Recent Developments/Updates
 Table 80. Taisho Company Information
 Table 81. Taisho Description and Business Overview
 Table 82. Taisho Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 83. Taisho Oxaprozin Product
 Table 84. Taisho Recent Developments/Updates
 Table 85. Ildong Company Information
 Table 86. Ildong Description and Business Overview
 Table 87. Ildong Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 88. Ildong Oxaprozin Product
 Table 89. Ildong Recent Developments/Updates
 Table 90. PD-Rx Pharmaceuticals Company Information
 Table 91. PD-Rx Pharmaceuticals Description and Business Overview
 Table 92. PD-Rx Pharmaceuticals Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 93. PD-Rx Pharmaceuticals Oxaprozin Product
 Table 94. PD-Rx Pharmaceuticals Recent Developments/Updates
 Table 95. Therapicon Company Information
 Table 96. Therapicon Description and Business Overview
 Table 97. Therapicon Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 98. Therapicon Oxaprozin Product
 Table 99. Therapicon Recent Developments/Updates
 Table 100. Neolpharma Company Information
 Table 101. Neolpharma Description and Business Overview
 Table 102. Neolpharma Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 103. Neolpharma Oxaprozin Product
 Table 104. Neolpharma Recent Developments/Updates
 Table 105. Apotex Corporation Company Information
 Table 106. Apotex Corporation Description and Business Overview
 Table 107. Apotex Corporation Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 108. Apotex Corporation Oxaprozin Product
 Table 109. Apotex Corporation Recent Developments/Updates
 Table 110. Yichang Dongyangguang Changjiang Pharmaceutical Company Information
 Table 111. Yichang Dongyangguang Changjiang Pharmaceutical Description and Business Overview
 Table 112. Yichang Dongyangguang Changjiang Pharmaceutical Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 113. Yichang Dongyangguang Changjiang Pharmaceutical Oxaprozin Product
 Table 114. Yichang Dongyangguang Changjiang Pharmaceutical Recent Developments/Updates
 Table 115. Hubei Baike Hengdi Pharmaceutical Company Information
 Table 116. Hubei Baike Hengdi Pharmaceutical Description and Business Overview
 Table 117. Hubei Baike Hengdi Pharmaceutical Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 118. Hubei Baike Hengdi Pharmaceutical Oxaprozin Product
 Table 119. Hubei Baike Hengdi Pharmaceutical Recent Developments/Updates
 Table 120. Fuan Pharmaceutical Group Company Information
 Table 121. Fuan Pharmaceutical Group Description and Business Overview
 Table 122. Fuan Pharmaceutical Group Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 123. Fuan Pharmaceutical Group Oxaprozin Product
 Table 124. Fuan Pharmaceutical Group Recent Developments/Updates
 Table 125. Hubei Baike Hengdi Pharmaceutical Company Information
 Table 126. Hubei Baike Hengdi Pharmaceutical Description and Business Overview
 Table 127. Hubei Baike Hengdi Pharmaceutical Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 128. Hubei Baike Hengdi Pharmaceutical Oxaprozin Product
 Table 129. Hubei Baike Hengdi Pharmaceutical Recent Developments/Updates
 Table 130. Pfizer Company Information
 Table 131. Pfizer Description and Business Overview
 Table 132. Pfizer Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 133. Pfizer Oxaprozin Product
 Table 134. Pfizer Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Oxaprozin Distributors List
 Table 138. Oxaprozin Customers List
 Table 139. Oxaprozin Market Trends
 Table 140. Oxaprozin Market Drivers
 Table 141. Oxaprozin Market Challenges
 Table 142. Oxaprozin Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Oxaprozin
 Figure 2. Global Oxaprozin Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Oxaprozin Market Share by Type: 2024 & 2031
 Figure 4. Tablets Product Picture
 Figure 5. Capsule Product Picture
 Figure 6. Global Oxaprozin Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Oxaprozin Market Share by Application: 2024 & 2031
 Figure 8. Rheumatoid Arthritis
 Figure 9. Chronic Infectious Arthritis
 Figure 10. Osteoarthritis
 Figure 11. Ankylosing Spondylitis
 Figure 12. Neck Shoulder Wrist Syndrome
 Figure 13. Periarthritis Of Shoulder
 Figure 14. Gout
 Figure 15. Anti-Inflammatory and Analgesic Effects After Trauma and Surgery
 Figure 16. Other
 Figure 17. Global Oxaprozin Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Oxaprozin Market Size (2020-2031) & (US$ Million)
 Figure 19. Global Oxaprozin Sales (2020-2031) & (KG)
 Figure 20. Global Oxaprozin Average Price (US$/G) & (2020-2031)
 Figure 21. Oxaprozin Report Years Considered
 Figure 22. Oxaprozin Sales Share by Manufacturers in 2024
 Figure 23. Global Oxaprozin Revenue Share by Manufacturers in 2024
 Figure 24. Global 5 and 10 Largest Oxaprozin Players: Market Share by Revenue in Oxaprozin in 2024
 Figure 25. Oxaprozin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Global Oxaprozin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 27. North America Oxaprozin Sales Market Share by Country (2020-2031)
 Figure 28. North America Oxaprozin Revenue Market Share by Country (2020-2031)
 Figure 29. U.S. Oxaprozin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Canada Oxaprozin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Europe Oxaprozin Sales Market Share by Country (2020-2031)
 Figure 32. Europe Oxaprozin Revenue Market Share by Country (2020-2031)
 Figure 33. Germany Oxaprozin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. France Oxaprozin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. U.K. Oxaprozin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Italy Oxaprozin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Russia Oxaprozin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Asia Pacific Oxaprozin Sales Market Share by Region (2020-2031)
 Figure 39. Asia Pacific Oxaprozin Revenue Market Share by Region (2020-2031)
 Figure 40. China Oxaprozin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Japan Oxaprozin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. South Korea Oxaprozin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. India Oxaprozin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Australia Oxaprozin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Taiwan Oxaprozin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Indonesia Oxaprozin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Thailand Oxaprozin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Malaysia Oxaprozin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Philippines Oxaprozin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Latin America Oxaprozin Sales Market Share by Country (2020-2031)
 Figure 51. Latin America Oxaprozin Revenue Market Share by Country (2020-2031)
 Figure 52. Mexico Oxaprozin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Brazil Oxaprozin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Argentina Oxaprozin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Middle East and Africa Oxaprozin Sales Market Share by Country (2020-2031)
 Figure 56. Middle East and Africa Oxaprozin Revenue Market Share by Country (2020-2031)
 Figure 57. Turkey Oxaprozin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Saudi Arabia Oxaprozin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. UAE Oxaprozin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 60. Global Sales Market Share of Oxaprozin by Type (2020-2031)
 Figure 61. Global Revenue Market Share of Oxaprozin by Type (2020-2031)
 Figure 62. Global Oxaprozin Price (US$/G) by Type (2020-2031)
 Figure 63. Global Sales Market Share of Oxaprozin by Application (2020-2031)
 Figure 64. Global Revenue Market Share of Oxaprozin by Application (2020-2031)
 Figure 65. Global Oxaprozin Price (US$/G) by Application (2020-2031)
 Figure 66. Oxaprozin Value Chain
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart